United States · FDA National Drug Code directory
Krystexxa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 75987-058_57c98104-8dbe-4e55-9cb6-7b101706b053
- Product NDC
- 75987-058
- Form
- INJECTION, SOLUTION
- Composition / generic term
- pegloticase
- Labeler
- Horizon Therapeutics USA, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250829
- Source listing expiry
- 20271231
Source-listed ingredients
- PEGLOTICASE — 8 mg/50mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (75987-058-01) / 50 mL in 1 VIAL · 75987-058-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →